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Abstract 
Proteomic analysis of extracellular matrix (ECM) and ECM-associated proteins, collectively 
known as the matrisome, is a challenging task due to the inherent complexity and insolubility 
of these proteins. Here we present sequential window acquisition of all theoretical fragment 
ion spectra mass spectrometry (SWATH MS) as a tool for the quantitative analysis of 
matrisomal proteins in both non-enriched and ECM enriched tissue without the need for prior 
fractionation. Utilising a spectral library containing 201 matrisomal proteins, we compared 
the performance and reproducibility of SWATH MS over conventional data-dependent 
analysis mass spectrometry (DDA MS) in unfractionated murine lung and liver. SWATH MS 
conferred a 15-20% increase in reproducible peptide identification across replicate 
experiments in both tissue types and identified 54% more matrisomal proteins in the liver 
versus DDA MS. We further use SWATH MS to evaluate the quantitative changes in 
matrisome content that accompanies ECM enrichment. Our data shows that ECM 
enrichment led to a systematic increase in core matrisomal proteins but resulted in 
significant losses in matrisome-associated proteins including the cathepsins and proteins of 
the S100 family. Our proof-of-principle study demonstrates the utility of SWATH MS as a 
versatile tool for in-depth characterisation of the matrisome in unfractionated and non-
enriched tissues. 
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Significance 
The matrisome is a complex network of extracellular matrix (ECM) and ECM-associated 
proteins that provides scaffolding function to tissues and plays important roles in the 
regulation of fundamental cellular processes. However, due to its inherent complexity and 
insolubility, proteomic studies of the matrisome typically require the application of enrichment 
workflows prior to MS analysis. Such enrichment strategies often lead to losses in soluble 
matrisome-associated components. In this study, we present sequential window acquisition 
of all theoretical fragment ion spectra mass spectrometry (SWATH MS) as a tool for the 
quantitative analysis of matrisomal proteins. We show that SWATH MS provides a more 
reproducible coverage of the matrisome compared to data-dependent analysis (DDA) MS. 
We also demonstrate that SWATH MS is capable of accurate quantification of matrisomal 
proteins without prior ECM enrichment and fractionation, which may simplify sample 
handling workflows and avoid losses in matrisome-associated proteins commonly linked to 
ECM enrichment. 
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Introduction 
The extracellular matrix (ECM) is a complex network of proteins whose primary scaffolding 
function confers integrity and elasticity to tissues and organs [1]. The ECM also provides 
important biochemical and biophysical cues required for the regulation of fundamental 
cellular processes including proliferation, differentiation, senescence and death [2]. The 
critical role of the ECM in human physiology is illustrated by a range of genetic diseases 
driven by dysregulation of key ECM components, such as osteogenesis imperfecta and 
Marfan syndrome [3-8]. Accurate proteomic characterisation the ECM has historically been 
challenging due to a lack of consensus of the protein constituents that make up the ECM. To 
address this challenge, an effort to integrate proteomic and genomic datasets has led to the 
generation of a database of ECM and ECM-associated proteins known as the in-silico 
matrisome [9, 10]. This matrisome database is divided into the “core matrisome” which 
consists of glycoproteins, collagens and proteoglycans subclasses, and the “matrisome-
associated proteins” that comprise affiliated proteins, regulators and secreted factors [10]. It 
should be noted that the matrisome database was designed to be inclusive and contains 
matrisome-associated proteins that are predicted to interact with ECM components. In 
particular, the interaction of multiple proteins within the “secreted factors” subclass with the 
ECM remains to be experimentally confirmed. 
 
Many components of the matrisome, in particular the core matrisomal proteins, are highly 
insoluble as a result of large size, extensive glycosylation and complex covalent crosslinking 
[11]. In addition, a number of matrisome-associated proteins are found in low abundance 
and may be obscured by the more abundant intracellular proteins. There has therefore been 
a need to develop ECM enrichment strategies that are capable of both solubilising 
matrisomal components and distinguishing these proteins from contaminating intracellular 
proteins that may otherwise dominate the acquired MS data in proteomic experiments [10, 
12-15]. We and others have shown that while the majority of these strategies lead to an 
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enrichment in core matrisome components, this is routinely accompanied by a concomitant 
decrease in the soluble matrisome-associated proteins [10, 12, 16]. The losses in 
matrisome-associated proteins stem from the multiple steps of enrichment, fractionation and 
washes associated with these ECM enrichment workflows. Such enrichment methods create 
a distorted view of the actual matrisomal content of the system under study, highlighting an 
urgent need for accurate methods capable of quantifying the matrisome with minimal 
enrichment and decellularisation of tissue specimens. 
 
The development of sequential window acquisition of all theoretical fragment ion spectra 
(SWATH) or data-independent acquisition (DIA) mass spectrometry (MS) has led to a new 
era of accurate and reproducible label-free quantification of proteomes [17, 18]. Unlike 
conventional data-dependent acquisition (DDA) MS which relies on the specific selection 
and fragmentation of a fixed number of (typically abundant) precursor ions in a survey scan, 
SWATH MS is based on the cyclical acquisition of precursor ions with fixed isolation 
windows that cover the entire m/z range. In this manner, all ionized precursor peptides within 
a sample are fragmented and their fragmentation spectra collected, enabling retrospective 
interrogation of the peptides of interest using spectral libraries [17]. SWATH MS combines 
the advantages of high reproducibility and sensitivity of targeted methods like selected 
reaction monitoring/multiple reaction monitoring (SRM/MRM) with the increased proteome 
depth typically seen with DDA MS [18, 19]. SWATH MS is versatile and has been used in 
diverse applications including the quantification of proteins in a number of model organisms, 
diseases states and bacteria [20-28]. SWATH MS has also been useful in characterising of 
low abundance sub-proteomes including post-translational modifications such as acetylation, 
succinylation and glycosylation [29-32].  
 
Here we describe the first study to utilise SWATH MS as a tool for robust identification and 
quantification of matrisomal proteins. By employing a spectral library containing 201 mouse 
matrisomal proteins, we show that this strategy outperforms DDA by providing a more 
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comprehensive and reproducible coverage of the matrisome while dispensing with the need 
for extensive fractionation in murine lung and liver tissue. We demonstrate that SWATH MS 
is capable of measuring both non-enriched and ECM enriched tissue lysates and use this 
method to highlight the scale of losses in matrisome-associated proteins resulting from ECM 
enrichment. This study illustrates the utility of SWATH MS as a valuable alternative for deep 
characterisation of matrisomal proteins from complex non-enriched tissues. 
 
Material and methods  
Animal models and tissue collection 
All animal work was carried out under UK Home Office project and personal licenses 
following local ethical approval from The Institute of Cancer Research Ethics Committee and 
in accordance with local and national guidelines. 6 liver and 6 lung tissue samples were 
dissected from 14-week-old to 18-week-old virgin female SCID Beige mice. Tissue samples 
were snap frozen in liquid nitrogen directly after excision and stored at -80 °C.  
 
Tissue processing 
Tissue samples were cut into small pieces, weighed and placed into precooled tubes 
containing PBS solution with 10 KIU/ml aprotinin (Sigma). Samples were washed for 30 min 
at 4 °C to remove excess blood. Samples were then transferred into homogenization buffer 
at 4 ml per g of tissue. The homogenization buffer is comprised of Tris-HCl (50mM, pH 7.4), 
0.25% 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate (CHAPS, 
Sigma), 25mM EDTA, 3M NaCl (Sigma) and 10 KIU/ml aprotinin. Tissue was homogenized 
2 x 30 sec on ice with a LabGEN700 homogenizer. The homogenized tissue was placed on 
a rotator (20 rpm) for 20 min at 4 °C. The resulting homogenate was split and subjected to 
one of two procotols as follows:  
a) Non-enriched samples: 1/3 of the homogenate was subjected to acetone precipitation by 
mixing with 4 volumes of ice cold acetone, vortexed and incubated 2 h at -20 °C to 
precipitate proteins. The precipitate was spun for 15 min at 15,000 rpm, 4 °C and the 
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supernatant removed. The resulting pellet was resuspended in 0.3 ml of urea buffer 
consisting of 8M urea, 100mM ammonium bicarbonate (ABC, Sigma), 25mM tris(2-
carboxyethyl)phosphine (TCEP, Sigma)) and stored at -80 °C.  
b) ECM enrichment: The remaining 2/3 of the homogenate was subjected to ECM 
enrichment as previously described by Hill et al. [12] with minor changes. The 
homogenate was spun for 15 min at 15,000 rpm, 4 °C, and the supernatant was 
removed. The pellet was resuspended in 0.5 ml of the fresh homogenization buffer and 
washed for two additional times in this buffer on a rotator (20 rpm) for 20 min at 4 °C. 
The CNBr digestion step of the original protocol was not performed and instead, the 
pellet after the third wash was directly resuspended in 0.3 ml of urea buffer and stored at 
-80 °C. 
 
The samples used for generation of the spectral library were not split after homogenization 
and the acetone precipitation protocol was applied to the whole tissue. Final protein 
concentration of all samples after resuspension in urea buffer was measured using the 
Pierce 660nm Protein assay as per manufacturer’s instructions (Thermo Scientific). 
 
Protein digestion and sample preparation 
400 µg of protein for spectral library generation or 100 μg of protein for all other experiments 
was reduced with 20mM dithiothreitol (DTT, Sigma), at 56 °C for 40 min and alkylated with 
30mM iodoacetamide (IAA, Sigma) at 25 °C for 25 min in the dark. To remove CHAPS, gel-
assisted digestion was performed as described previously [33]. Briefly, a mixture of 30% 
(v/v) acrylamide/bisacrylamide (29:1), 10% (w/v) APS and TEMED was added directly to the 
tube with alkylated proteins and allowed to polymerize in air at room temperature. The 
resulting gel was cut into small cubes and sequentially dehydrated with 50% ACN in 50mM 
ABC and 100% ACN. Compared to original protocol [33], a solution with twice the 
concentration of trypsin (25ng/ml in 100mM ABC) was added to the dry gel cubes and 
incubated for 30 min at 4 °C followed by addition of 100mM ABC to suspend all the gel 
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cubes. Proteins were left to digest overnight at 37 °C. After digestion, samples were spun for 
15 min at 15,000 rpm, 4 °C, and the supernatant with digested peptides was removed. The 
gel cubes were subjected to three additional extractions for 10 min in 60% ACN, 0.1% TFA. 
Pooled supernatant and extracts were dried in a SpeedVac concentrator and desalted with 
OPTI trap cartridges (Optimize Technologies). 
 
Strong cation exchange (SCX) chromatography 
Tryptic digests from non-enriched sample preparations of 2 lung and 2 liver samples were 
selected for the generation of the spectral library. 400 μg of the digested samples were 
resuspended in 20 μl of Buffer A (10 mM KH2PO4 in 20% ACN, pH 2.65) and loaded on a 
2.1 x 100 mm Polysulfoethyl A column with 5 μm, 200 Å particles (PolyLC Inc.) for SCX 
fractionation. The peptides were eluted at a flow rate of 0.2 ml/min by Buffer B (10 mM 
KH2PO4, 500mM NaCl in 20% ACN, pH 2.65) with a gradient of 0-10% of B for 2.5 min, 10-
50% of B for 20 min, 50-100% B for 7.5 min followed by an additional 10 min elution with 
100% B. 12 fractions were collected over 39 min with fraction 1 collected from 0 to 12 min 
and fraction 12 from 32 to 39 min. The remaining 10 fractions were collected at 2 min 
intervals between 12 to 32 min. All SCX fractions were dried in a SpeedVac concentrator, 
then resuspended in 0.1% TFA and desalted with C18 OMIX tips (Agilent Technologies).  
 
DDA MS data acquisition 
For liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, non-enriched 
unfractionated samples and SCX fractions were dissolved in Buffer A (2% ACN, 0.1% FA), 
spiked with iRT calibration mix (Biognosys AG) and analyzed on an Agilent 1260 HPLC 
system coupled to a TripleTOF 5600+ mass spectrometer with NanoSource III (AB SCIEX). 
1 μg of peptides for each sample was loaded onto a ZORBAX C18 (Agilent Technologies) 
trap column and separated on a 75 μm x 15 cm long analytical column with an integrated 
manually pulled tip packed with Reprosil Pur C18AQ beads (3 μm, 120 Å particles, Dr. 
Maisch) with a linear gradient of 2-40% of Buffer B (98% ACN, 0.1% FA) in 90 min and a 
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flow rate of 250 nl/min. Full profile MS scans were acquired in the mass range of m/z 340-
1500 in positive ion mode. The top 20 most intense ions with charge state from 2+ to 5+ were 
selected for fragmentation and MS/MS scans were acquired in mass range of m/z 100-1500. 
Maximum filling time for MS scans was 250 ms, for MS/MS scans 100 ms and dynamic 
exclusion of fragmented ions was set to 12 s. 
 
SWATH MS data acquisition 
SWATH MS data for both non-enriched and enriched unfractionated samples were acquired 
on the same MS instrument using the identical LC conditions. Full profile MS scans were 
acquired in mass range of m/z 340-1400 in positive ion mode. As previously described by 
Bruderer et al.[34], 8 data points per elution peak were set-up for calculation of 31 precursor 
isolation windows with a fixed size of 25 Da across the mass range of m/z 350-1250 with 1 
Da overlap. MS/MS scans were acquired in the mass range of m/z 100-1500. Maximum 
filling time for MS scans was 250 ms and for MS/MS scans 100 ms, resulting in a cycle time 
of 3.3 s.  
 
Spectral library generation 
The 2 liver and 2 lung samples that were fractionated by SCX were used for building the 
spectral library. Acquired DDA datasets were searched by ProteinPilot 5.0.1 software (AB 
SCIEX) against a Uniprot mouse database (downloaded on 20/10/2017) with added iRT 
sequence. Each dataset comprised of 12 DDA runs for 12 individual SCX fractions, which 
were combined during the search. Overall 4 datasets were searched, 2 each for liver and 
lung. The Spectronaut 11 software (Biognosys AG) [19] was used to generate four spectral 
libraries from the resulting ProteinPilot group files using following settings: maximum 2 
missed cleavages, carbamidomethylation of cysteines set as fixed modification, asparagine 
and glutamine deamidation, oxidation of methionine and hydroxylation of lysine and proline 
were set as variable modifications, precursor charge state from 2+ to 5+, 99% confidence of 
the correct peptide identification. Other parameters were used in default settings. The 
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generated libraries were then merged into a final spectral library containing 41741 
precursors from 5050 protein groups. 
 
Data processing and statistical analysis 
DDA data for non-enriched samples were searched by ProteinPilot 5.0.1 software (AB 
SCIEX) against a Uniprot mouse database (downloaded on 20/10/2017) with added iRT 
sequences. The search parameters were as follows: maximum 2 missed cleavages, 
carbamidomethylation of cysteines set as fixed modification, biological modification, urea 
denaturation and collagen emphasis in ProteinPilot were selected as variable modifications.  
For comparison with SWATH, only peptides with 99% confidence of the correct identification 
(with an average peptide-to-spectrum match false discovery rate (PSM-FDR) [35] of 1%) and 
proteins with a (protein-to-peptide) FDR below 5%  were selected for analysis. 
 
The acquired SWATH data were analysed using the Spectronaut 11 software with the 
default analysis settings and the following minor changes: FDR of protein identification was 
set to 5% (with PSM-FDR threshold maintained at 1%) and maximum number of 6 
precursors was used for quantification. Peak area of fragment ions was used for peptide 
quantification. To quantify proteins, the mean value of the peptides quantities was 
calculated. Results of protein quantification were exported as a tsv file and further processed 
and statistically analysed in Perseus (ver. 1.5.6.0) [36]. All data were log2 transformed and 
the differences in protein levels were compared by Welch’s t-test with Benjamini’s-
Hochberg’s correction of p-value [35]. The resulting q-value of 0.1 was set as a cut-off. 
Datasets were further Z-normalized and hierarchically clustered based on Euclidean 
distance.  
 
The MS data has been deposited to the ProteomeXchange Consortium via the PRIDE [37] 
partner repository with the dataset identifier PXD008651. 
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Results  
Spectral library generation 
Spectral libraries are required for effective post-acquisition deconvolution and processing of 
SWATH MS data [17]. These spectral libraries contain parameters such as m/z value, 
intensities and retention times for all precursors and their respective ion fragments 
(transitions), which are extracted from prior discovery DDA MS experiments [38]. There is no 
publicly available spectral library for Mus musculus on SWATHAtlas (www.swathatlas.org) 
and we sought to first generate such a library based on mouse liver and lung tissue 
homogenates. Tissue homogenates were subjected to SCX fractionation in 2 biological 
replicates and each of the 12 fractions run in DDA mode with spiked indexed retention time 
calibration (iRT) peptides. The Spectronaut 11 software [19] was used to combine the data 
from the 4 experiments (2 replicates each of liver and lung) to generate a spectral library 
containing 41741 precursors in 5050 protein groups, including 201 matrisomal protein (Table 
1, Supplemental table S1). The scheme of the workflow for spectral library generation as 
well as for sample processing is depicted in Figure 1. 
 
Comparison of DDA and SWATH MS matrisome analysis 
As a result of stochastic precursor selection and fragmentation, DDA MS suffers from a well-
documented shortcoming of poor reproducibility in the identification (ID) of peptides between 
different experiments [39]. In contrast, since the fragmentation ions for all peptide precursors 
in the scanned mass range are acquired in a SWATH MS experiment, this strategy has 
previously been shown to significantly enhance reproducibility in peptide IDs [18, 19, 40]. To 
ascertain if this increased reproducibility is also applicable to the matrisome, we performed a 
comparative analysis of the performance of DDA versus SWATH MS in mouse liver and lung 
tissues. 
 
We first determined the number of matrisome proteins that were reproducibly identified in 
two biological replicates of unfractionated mouse liver and lung (each biological replicate 
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was measured in three technical replicates). To avoid any bias associated with ECM 
enrichment pre-processing steps, we performed this analysis using non-enriched tissue 
lysates. DDA analysis of the liver samples resulted in the ID of 50 matrisomal proteins (Table 
2, Supplemental Table S2), while SWATH MS analysis of identical samples identified 77 
matrisomal proteins. 46 proteins were common between the two methods with 4 matrisomal 
proteins identified exclusively by DDA and 31 proteins identified exclusively by SWATH 
(Figure 2A). In the lung tissue, 108 and 116 matrisomal proteins were identified by DDA and 
SWATH MS respectively (Table 2, Supplemental Table S2), with 14 matrisomal proteins 
identified only by DDA compared to 22 matrisomal proteins exclusively detected by SWATH 
MS (Figure 2B). With a 54% increase in the number of protein IDs, our data suggests that in 
the context of the liver, SWATH MS is superior to DDA for matrisomal protein ID. However, 
the number of proteins identified in the lung by both DDA and SWATH MS is comparable. 
This data indicates that the benefit of SWATH over DDA MS in the number of unique 
matrisomal protein IDs may be tissue dependent.  
 
To assess the reproducibility of peptide IDs between both methods, we compared the data 
from three technical replicates of the same liver and lung samples. DDA identified a higher 
total number of unique matrisomal peptides versus SWATH MS (Figure 2C and D). 
However, in both the liver and lung tissue, SWATH MS outperforms DDA in the 
reproducibility of peptides identified across all three technical replicate analyses. 
Reproducibility of SWATH MS in the liver was 58.6% while DDA was only 43.9% (Figure 
2C). Similarly in lung, reproducibility of SWATH MS was 78.6% compared to 56.8 % 
obtained by DDA (Figure 2D). This 15-20% improvement agrees with previous reports that 
SWATH MS is superior to DDA in run-to-run reproducibility in peptide IDs [18, 19, 40].  
 
Quantitative comparison of the lung and liver matrisome by SWATH MS 
A further benefit afforded by SWATH over DDA MS is the ability to perform more precise 
label free quantification by comparing of signal intensities or peak areas of peptide-specific 
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transitions [17]. We have previously undertaken a DDA MS-based comparison of murine 
liver and lung and demonstrated that while both organs share a common subset of 
matrisome components, the lung contains more unique matrisomal proteins versus the liver 
[16]. However, our previous study was qualitative in nature, limiting our ability to make 
conclusions about the quantitative differences in matrisomal content that is common to both 
organs. In addition, we cannot rule out the possibility that the matrisomal proteins found 
exclusively in the lung was not due to missed peptide precursors resulting from stochastic 
precursor ion selection in the DDA MS analysis of the liver.  
 
Analysis of 6 non-enriched liver and lung samples (each measured in three technical 
replicates) resulted in the ID of 126 matrisomal proteins, 95 proteins of which were found in 
the liver and 121 in the lung (Figure 3A, Supplemental Table S3). Of these proteins, 31 and 
5 proteins were unique to the lung or liver respectively. As expected, the lung surfactant 
lipoproteins Sftpa1, Sftpb and Sftpc (affiliated proteins) were among the proteins found only 
in the lung. Other proteins exclusively identified in the lung include the glycoproteins Agrin 
(Agrn) and von Willebrand factor (Vwf), and the proteoglycan Asporin (Aspn). Absence of 
these proteins in liver matrisome is consistent with our previously published data [16]. Of the 
90 matrisomal proteins that were common in both tissue types (Figure 3B), 59 proteins were 
found to be significantly altered between the lung and liver (Table 3). The majority of these 
matrisomal proteins (55 proteins) were significantly increased in lung and include the 
important structural proteins Elastin (Eln, log2 fold change 3.62,) and Collagen IV (Col4a2, 
log2 fold change 3.7) (Figure 3C). Only 4 proteins were found to be significantly increased in 
liver compared to lung. These are Laminin subunit alpha-2 (Lama2, log2 fold change 3.2), 
Mannose binding protein C (Mbl2, log2 fold change 1.1), Cathepsin Z (Ctsz, log2 fold 
change 0.51) and Galectin 9 (Lgals9, log2 fold change 2.47) (Figure 3D). Our analysis 
confirms previous findings that the lung contains significantly higher levels of matrisomal 
proteins versus the liver [16] and highlights the ability of SWATH MS to perform quantitative 
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comparisons of the matrisomal content between different tissue types in unfractionated and 
non-enriched tissue.  
 
 
SWATH MS as a tool for characterising the matrisomal alterations associated with 
ECM enrichment  
In our previous study, we performed a qualitative comparison of four ECM enrichment 
protocols on matrisome protein ID in four different murine tissue types and showed that all 
four ECM enrichment methods led to significant losses in soluble matrisome-associated 
proteins [16]. Here, we applied SWATH MS to quantitatively characterise the effects of ECM 
enrichment on matrisomal protein content by comparing non-enriched versus ECM-enriched 
liver and lung tissue. ECM was enriched by utilising a method originally developed by Hill et 
al. [12] with minor alterations. This method involves the use of a chemical digestion step by 
CNBr to aid in the solubilisation of the urea-insoluble ECM fraction prior to trypsin digestion. 
Given that the samples used for the generation of the spectral library were not digested by 
CNBr, we excluded this step from the working protocol. Instead, samples were digested after 
resuspension in urea buffer using an increased concentration of trypsin.  
 
In the liver tissue, we quantified 68 matrisomal proteins in ECM enriched samples and 73 
proteins in the non-enriched samples (Figure 4A, Supplemental table S4). 8 matrisomal 
proteins were found only in enriched samples and include 6 glycoproteins, 1 collagen and 1 
proteoglycan; all proteins belonging to the core matrisome class. In contrast, 13 proteins 
primarily composed of the matrisome-associated class (2 affiliated proteins, 10 regulators 
and 1 glycoprotein) were detected exclusively in the non-enriched samples. 4 cathepsins 
(regulators) and 4 serpins (regulators) were lost during the enrichment. Among the 60 
matrisomal proteins quantified in both sample groups (Figure 4B), 35 were found to be 
significantly altered (Table 4). As expected, the vast majority of matrisome proteins showed 
a significant upregulation in the ECM enriched compared to the non-enriched samples 
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(Table 4). Of the 31 matrisomal proteins that were upregulated in the enriched samples, 24 
belong to the core matrisome with EMILIN-1 (Emilin1) and Mimecan (Ogn) showing the 
highest increase with a log2 fold change of 5.08 and 5.01, respectively. 4 matrisome-
associated proteins were significantly decreased after enrichment, specifically Annexin A6 
(Anxa6), Cathepsin D (Ctsd), Protein ERGIC-53 (Lman1) and Alpha-1-antitrypsin 1-3 
(Serpina1c). The largest decrease was found in Anxa6, whose levels in enriched samples 
was almost 5 times lower (log2 fold change -2.24) compared to the non-enriched samples.  
 
In the SWATH analysis of the lung specimens, 104 and 111 matrisomal proteins were 
identified in the enriched and non-enriched samples, respectively (Figure 4C, Supplemental 
table S5). Protein transglutaminase K (Tgm1, affiliated protein) was the only unique protein 
in the enriched samples while 8 matrisome-associated proteins (2 affiliated proteins, 2 
regulators, 4 secreted factors) were found exclusively in the non-enriched lungs (Figure. 4C). 
Similar to the liver, ECM enrichment resulted in the loss of 2 cathepsins as well as 4 
members of the S100 protein family (secreted proteins). Of the 103 proteins common 
between the two sample preparation workflows (Figure 4D), 71 matrisomal proteins were 
significantly altered (Table 5). Similar to the liver samples, ECM enrichment resulted in the 
increase of a large proportion of the altered matrisomal proteins. Of the 53 matrisomal 
proteins that are significantly increased, 45 belong to the core matrisome. However, ECM 
enrichment also led to the decrease of 16 matrisome-associated proteins, including 7 of 8 
identified Annexins (affiliated proteins), all identified Alpha-1-antitrypsins (regulator) and 
Epidermal growth factor-like protein 7 (Egfl7, secreted factor)  
 
Our comparative analysis demonstrates that ECM enrichment significantly alters the 
matrisome composition identified in proteomic experiments with a general increase in core 
matrisomal components and a reduction in the levels of matrisome-associated proteins.  
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Discussion 
In this study, we have provided the first proof-of-principle application of SWATH MS in the 
quantitative characterisation of matrisomal proteins. This involves the development of a 
murine specific spectral library comprising 201 matrisomal proteins across all six subclasses 
in both core matrisome and matrisome-associated proteins. We demonstrate the general 
applicability of this approach in measuring the matrisomal content in two different tissue 
types as well as in both non-enriched and ECM-enriched lysates. We anticipate that with 
further refinements in spectral library generation and the use of other species-specific 
spectral libraries, this strategy can be readily extended to studying different disease states in 
multiple organisms.  
 
While DDA MS has been the foundation of modern proteomics for more than two decades, 
we show that SWATH MS confers three major advantages in the characterisation of the 
matrisome. The first key advantage is increased reproducibility between experiments, as 
SWATH MS does not suffer from the drawback of precursor ion undersampling in complex 
samples routinely found in DDA MS experiments. In line with previously published SWATH 
studies [18, 19, 40], our data demonstrates that SWATH MS increases the reproducibility of 
peptide IDs by 15-20% across multiple technical replicates. The second advantage of 
SWATH MS is a more comprehensive characterisation of the liver matrisome where a 54% 
increase in protein IDs was observed compared to DDA MS of the same samples. Unlike 
DDA MS, SWATH is not dependent on precursor ion selection and fragments all ions in pre-
defined isolation windows. Therefore, even precursors with low signal intensities are 
fragmented and fragmentation ion spectra acquired. This increased benefit was not 
observed in the context of the lung which suggests that SWATH analysis may be particularly 
useful in tissues with low ECM content such as the liver where low intensity matrisomal 
peptide precursors may be obscured by the more abundant intracellular proteins and missed 
in DDA mode [41]. Alternatively, distinct patterns of post-translational modifications (PTMs) 
in matrisomal proteins (such as glycosylation) between the liver and lung may skew the DDA 
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MS protein ID rates. Future work incorporating PTMs into the spectral library will enable a 
more comprehensive interrogation of the basis for the observed tissue dependent benefit of 
SWATH MS. Finally, SWATH MS enables precise label-free quantification and we exploit 
this property to accurately quantify matrisomal alterations between two tissue types and 
compare distinct sample preparation workflows.  
 
There are some limitations to the SWATH MS strategy. As with all targeted MS approaches, 
the number of proteins identified in a SWATH MS analysis is largely limited by the 
composition of the spectral library. Our spectral library consists of 201 matrisomal proteins 
which is only a fraction of the reported proteins found in the in silico matrisome database 
[10]. Future work will involve significantly increasing the spectral library by incorporating 
further discovery-based DDA analysis of additional murine tissue and cell types. It should be 
noted that since existing SWATH MS datasets can be retrospectively analysed with new 
spectral libraries, there is no requirement for additional experiments to re-acquire MS data. 
Furthermore, our spectral library is currently limited to trypsin digested peptides which 
restricts our analysis to urea soluble ECM components. With advances in sample 
preparation techniques including the use of hydroxylamine as a means to chemically digest 
insoluble ECM components [42], we anticipate that the depth of matrisome coverage can be 
readily improved by generating spectral libraries that include chemical digested peptides. 
Another limitation is that it is currently not possible to perform multiplex experiments in 
SWATH MS, restricting its application in large-scale experiments that have been previously 
reported with matrisomal analysis using DDA-specific isobaric chemical labelling strategies 
such as iTRAQ or TMT [43-45].  
 
The majority of published matrisomal proteomics studies have employed extensive 
fractionation and/or ECM enrichment in order to enhance the number of proteins identified. 
We demonstrate the utility of SWATH MS in identifying a comparable number of matrisomal 
proteins in non-enriched unfractionated samples. For instance, Gocheva et al. [43] very 
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recently identified 113 matrisomal proteins in murine lung in a workflow that included ECM-
enrichment and off-gel fractionation. This number is comparable with the 121 matrisomal 
proteins we identified in our SWATH MS analysis of non-enriched unfractionated lungs. By 
quantitatively measuring the changes in matrisomal proteins associated with ECM 
enrichment, we further show that these workflows result in a systematic bias where a gain in 
core matrisome proteins is accompanied by losses in matrisome-associated proteins. Such 
losses in matrisome-associated proteins arising from ECM enrichment have previously been 
documented [12, 16]. Our analysis finds that in some cases, specific matrisome-associated 
proteins such as the cathepsins and members of the S100 protein family are completely lost, 
highlighting a subset of the matrisome which is inaccessible by current ECM enrichment 
workflows; and may only be amenable to analysis by alternative approaches such as 
SWATH MS or ultra-deep proteomic sequencing of non-enriched samples. However, as with 
all proteomic enrichment strategies, these losses need to be balanced with any requirements 
for improved detection and quantification of low abundance as well as insoluble core 
matrisome proteins afforded by the use of ECM enrichment.  
 
Conclusion 
In summary, our current study finds that the SWATH MS strategy is a versatile tool for the 
quantitative analysis of non-enriched and ECM enriched tissue lysates without the need for 
prior fractionation. We show that this approach is capable of accurately quantifying 
matrisomal proteins in non-enriched tissue to a similar depth as ECM-enriched lysates, 
indicating that this methodology may reduce the requirements for extensive ECM enrichment 
in future studies, not only simplifying sample handling, but also avoiding associated losses in 
matrisome-associated proteins.  
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Figure legends: 
 
Figure 1: Schematic of the experimental workflow employed in this study. Key steps 
that were undertaken for the generation of the spectral library (blue) and sample processing, 
data acquisition and analysis (orange) in this study are highlighted. 
 
Figure 2: Comparative analysis of the performance of SWATH MS versus DDA MS.  
Venn diagrams depicting number and overlap of matrisomal proteins detected by DDA and 
SWATH MS in A) liver and B) lung tissue across 2 biological replicates and 3 technical 
replicates. Proteins uniquely identified by each method are highlighted. Venn diagrams 
depicting the number and overlap of unique matrisome peptides identified in C) liver and D) 
lung tissue across 3 technical replicates (R1-R3) in DDA and SWATH MS. Only peptides 
with 99% confidence of identification or higher were compared. 
 
Figure 3: Comparative analysis of the liver and lung matrisome by SWATH MS.  
A) Venn diagram depicting the number and overlap of unique matrisomal proteins quantified 
by SWATH MS in liver and lung tissue across 6 biological replicates. B) A heatmap of the 90 
common matrisomal proteins that were quantified in both liver and lung tissue (n=6). 
Samples were subjected to two-way hierarchical clustering based on Euclidian distance.  
Relative quantification of C) Collagen IV and D) Galectin-9 in liver and lung tissue across the 
6 biological replicates. Mean Log2 signal peak area from 3 technical replicates of each 
sample is shown with the standard deviation. 
 
Figure 4: Effect of ECM enrichment on the matrisomal content in liver and lung as 
measured by SWATH MS.  
Venn diagram depicting the number and overlap of unique matrisomal proteins in ECM 
enriched versus non-enriched samples in A) liver and B) lung tissue across 6 biological 
replicates. Heatmaps of the common matrisomal proteins that were quantified in both ECM 
enriched and non-enriched samples in C) liver and D) lung tissue (n=6). Samples were 
subjected to two way hierarchical clustering based on Euclidian distance. Core matrisomal 
proteins (black text) and matrisome associated proteins (orange text) are highlighted to 
illustrate gains in core matrisome proteins and losses in matrisome-associated proteins as a 
result of ECM enrichment. 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
24 
 
Table 1: Number of matrisomal proteins in the spectral library. More details can be found in 
Supplemental Table S1. 
 
  
Matrisomal class 
Number of proteins in 
spectral library 
Glycoproteins 62 
Collagens 14 
Proteoglycans 9 
Affiliated proteins 37 
Regulators 59 
Secreted factors 20 
Total 201 
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Table 2: Number of identified matrisomal proteins in mouse liver and lung tissue by DDA 
versus SWATH MS. More details can be found in Supplemental Table S2. 
 
  
 
Liver Lung 
DDA SWATH DDA SWATH 
Glycoproteins 7 20 38 39 
Collagens 9 9 11 10 
Proteoglycans 4 6 7 7 
Affiliated proteins 10 16 20 20 
Regulators 20 26 25 32 
Secreted factors 0 0 7 8 
Total 50 77 108 116 
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Table 3: List of matrisomal proteins identified in both lung and liver tissue, whose expression 
levels are significantly altered. 
 
Class 
Gene 
Name 
Protein Name 
Lung/Liver 
Log2 fold 
change 
q-value 
G
ly
c
o
p
ro
te
in
s
 
Eln Elastin 3.62 3.30E-04 
Emilin1 EMILIN-1 4.20 2.72E-03 
Fbn1 Fibrillin-1 5.14 1.67E-04 
Fga Fibrinogen alpha chain 1.57 3.53E-05 
Fgb Fibrinogen beta chain 1.86 2.82E-05 
Fgg Fibrinogen gamma chain 2.08 2.15E-05 
Fn1 Fibronectin 1.12 4.11E-04 
Lama2 Laminin subunit alpha-2 -3.20 1.71E-02 
Lama3 Laminin subunit alpha-3 2.42 5.99E-02 
Lama4 Laminin subunit alpha-4 2.16 2.90E-04 
Lama5 Laminin subunit alpha-5 3.28 2.29E-03 
Lamb2 Laminin subunit beta-2 4.03 1.77E-02 
Lamc1 Laminin subunit gamma-1 1.27 1.23E-03 
Nid2 Nidogen-2 2.53 2.93E-03 
Tinagl1 
Tubulointerstitial nephritis antigen-
like 
2.47 2.25E-05 
Vtn Vitronectin 1.12 4.27E-02 
Vwa5a 
von Willebrand factor A domain-
containing protein 5A 
1.64 9.28E-05 
C
o
ll
a
g
e
n
s
 Col18a1 Collagen alpha-1(XVIII) chain 1.26 4.09E-03 
Col1a1 Collagen alpha-1(I) chain 2.10 2.93E-03 
Col1a2 Collagen alpha-2(I) chain 1.37 2.51E-02 
Col4a1 Collagen alpha-1(IV) chain 2.48 2.12E-04 
Col4a2 Collagen alpha-2(IV) chain 3.70 1.99E-08 
Col6a1 Collagen alpha-1(VI) chain 2.74 2.63E-06 
P
ro
te
o
g
ly
c
a
n
s
 
Bgn Biglycan 2.10 5.02E-04 
Dcn Decorin 1.55 2.37E-03 
Hspg2 Perlecan 2.68 7.63E-09 
Lum Lumican 2.69 6.87E-07 
Ogn Mimecan 4.86 2.05E-02 
Prelp Prolargin 1.87 3.77E-03 
A
ff
il
ia
te
d
 p
ro
te
in
s
 
Anxa1 Annexin A1 3.93 3.97E-02 
Anxa11 Annexin A11 1.18 1.84E-03 
Anxa2 Annexin A2 2.94 9.73E-11 
Anxa3 Annexin A3 3.58 1.28E-03 
Anxa4 Annexin A4 1.55 1.72E-04 
Anxa5 Annexin A5 3.39 1.51E-11 
Anxa6 Annexin A6 0.62 8.24E-04 
Anxa7 Annexin A7 0.62 3.45E-04 
Clec4f 
C-type lectin domain family 4 
member F 
0.65 4.04E-02 
Colec12 Collectin-12 1.85 4.30E-02 
Hpx Hemopexin 1.38 1.96E-02 
Lgals9 Galectin-9 -2.47 1.85E-05 
Mbl2 Mannose-binding protein C -1.10 1.23E-03 
R
e
g
u
la
to
rs
 Cstb Cystatin-B 1.04 2.29E-02 
Ctsc Dipeptidyl peptidase 1 0.47 2.25E-03 
Ctsd Cathepsin D 0.47 6.23E-03 
Ctsz Cathepsin Z -0.51 7.35E-03 
Itih4 
Inter alpha-trypsin inhibitor, heavy 
chain 4 
1.28 2.37E-02 
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Kng1 Kininogen-1 1.62 1.38E-04 
Plg Plasminogen 0.34 8.07E-02 
Pzp Pregnancy zone protein 0.99 5.48E-04 
Serpina1b Alpha-1-antitrypsin 1-2 0.90 1.08E-03 
Serpina1c Alpha-1-antitrypsin 1-3 1.57 3.43E-05 
Serpina1d Alpha-1-antitrypsin 1-4 1.17 5.81E-04 
Serpina1e Alpha-1-antitrypsin 1-5 1.03 2.27E-05 
Serpina3k Serine protease inhibitor A3K 1.28 2.74E-04 
Serpina3m Serine protease inhibitor A3M 1.01 8.12E-02 
Serpinc1 Antithrombin-III 1.27 1.30E-03 
Serpinf2 Alpha-2-antiplasmin 1.94 5.68E-02 
Serpinh1 Serpin H1 2.49 9.52E-09 
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Table 4: List of liver matrisomal proteins identified in both ECM enriched and non-enriched 
samples, whose levels were significantly altered by enrichment. 
 
Class 
Gene 
Name 
Protein Name 
Enriched to non-
enriched Log2 fold 
change 
q-value 
P
ro
te
o
g
ly
c
a
n
s
 
Eln Elastin 2.88 1.46E-05 
Emilin1 EMILIN-1 5.08 6.52E-04 
Fga Fibrinogen alpha chain 2.51 2.05E-05 
Fgb Fibrinogen beta chain 2.68 1.40E-06 
Fgg Fibrinogen gamma chain 1.64 5.82E-05 
Fn1 Fibronectin 3.63 2.07E-08 
Lama4 Laminin subunit alpha-4 1.85 2.83E-03 
Lamb2 Laminin subunit beta-2 4.27 3.37E-04 
Lamc1 Laminin subunit gamma-1 0.43 9.47E-02 
Nid2 Nidogen-2 3.66 4.54E-03 
Tinagl1 
Tubulointerstitial nephritis antigen-
like 
3.83 1.54E-05 
C
o
ll
a
g
e
n
s
 
Col14a1 Collagen alpha-1(XIV) chain 2.55 1.01E-06 
Col18a1 Collagen alpha-1(XVIII) chain; 3.73 2.01E-05 
Col1a1 Collagen alpha-1(I) chain 3.88 1.27E-05 
Col1a2 Collagen alpha-2(I) chain 3.31 1.18E-05 
Col4a1 Collagen alpha-1(IV) chain 3.64 3.52E-06 
Col4a2 Collagen alpha-2(IV) chain 3.15 2.25E-06 
Col6a1 Collagen alpha-1(VI) chain 3.86 1.38E-05 
P
ro
te
o
g
ly
c
a
n
s
 
Bgn Biglycan 1.80 2.39E-03 
Dcn Decorin 2.59 5.02E-08 
Hspg2 Perlecan 3.58 1.46E-06 
Lum Lumican 3.13 4.71E-04 
Ogn Mimecan 5.01 7.32E-03 
Prelp Prolargin 1.82 2.77E-04 
A
ff
il
ia
te
d
 
p
ro
te
in
s
 
Anxa11 Annexin A11 0.88 5.18E-02 
Anxa6 Annexin A6 -2.24 3.00E-04 
Anxa7 Annexin A7 1.97 1.52E-06 
Lgals8 Galectin-8 1.40 3.64E-04 
Lgals9 Galectin-9 0.46 3.48E-02 
Lman1 Protein ERGIC-53 -1.08 2.33E-03 
S
e
c
re
te
d
 
p
ro
te
in
s
 
Ctsd Cathepsin D -0.46 5.34E-03 
Plg Plasminogen 0.98 7.46E-03 
Serpina1c Alpha-1-antitrypsin 1-3 -0.93 2.73E-04 
Serpinh1 Serpin H1 2.40 1.19E-06 
Tgm2 
Protein-glutamine gamma-
glutamyltransferase 2 
2.82 1.36E-06 
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Table 5: List of lung matrisomal proteins identified in both ECM enriched and non-enriched 
samples, whose levels were significantly altered by enrichment. 
 
Class 
Gene 
Name 
Protein Name 
Enriched to non-
enriched Log2 fold 
change 
q-value 
G
ly
c
o
p
ro
te
in
s
 
Adipoq Adiponectin -0.95 3.08E-03 
Agrn Agrin 1.54 1.15E-03 
Aspn Asporin 1.89 1.88E-03 
Dpt Dermatopontin 1.25 3.35E-04 
Ecm1 Extracellular matrix protein 1 1.64 1.01E-04 
Eln Elastin 2.56 5.80E-04 
Emilin1 EMILIN-1 1.92 9.73E-09 
Fbln1 Fibulin-1 0.38 2.42E-02 
Fbln5 Fibulin-5 2.06 3.44E-08 
Fbn1 Fibrillin-1 1.17 3.60E-03 
Fga Fibrinogen alpha chain 1.59 2.04E-06 
Fgb Fibrinogen beta chain 1.74 1.45E-06 
Fgg Fibrinogen gamma chain 0.85 1.33E-02 
Fn1 Fibronectin 2.53 3.56E-07 
Igfbp6 
Insulin-like growth factor-binding 
protein 6 
-0.99 1.10E-02 
Lama3 Laminin subunit alpha-3 1.87 2.38E-06 
Lama4 Laminin subunit alpha-4 1.38 2.32E-05 
Lama5 Laminin subunit alpha-5 2.11 5.94E-06 
Lamb1 Laminin subunit beta-1 1.20 2.31E-06 
Lamb2 Laminin subunit beta-2 2.05 4.34E-07 
Lamb3 Laminin subunit beta-3 2.14 2.33E-06 
Lamc1 Laminin subunit gamma-1 2.36 3.25E-07 
Lamc2 Laminin subunit gamma-2 1.27 3.39E-05 
Mmrn1 Multimerin-1 6.16 3.85E-03 
Nid1 Nidogen-1 1.64 8.56E-06 
Nid2 Nidogen-2 1.71 4.83E-08 
Npnt Nephronectin 1.87 1.90E-06 
Postn Periostin 2.00 1.40E-06 
Tinagl1 
Tubulointerstitial nephritis antigen-
like 
0.89 2.21E-03 
Vtn Vitronectin 1.57 1.98E-05 
Vwf von Willebrand factor 1.54 5.47E-04 
C
o
ll
a
g
e
n
s
 
Col12a1 Collagen alpha-1(XII) chain 2.05 3.87E-06 
Col14a1 Collagen alpha-1(XIV) chain 4.33 4.35E-03 
Col15a1 Collagen alpha-1(XV) chain 1.49 7.94E-03 
Col18a1 Collagen alpha-1(XVIII) chain 2.40 1.31E-06 
Col1a1 Collagen alpha-1(I) chain 1.72 1.68E-02 
Col4a1 Collagen alpha-1(IV) chain 2.61 3.51E-04 
Col4a2 Collagen alpha-2(IV) chain 2.21 1.76E-06 
Col6a1 Collagen alpha-1(VI) chain 2.15 2.00E-06 
Col6a2 Collagen alpha-2(VI) chain 1.84 1.01E-05 
P
ro
te
o
g
ly
c
a
n
s
 Bgn Biglycan 1.09 1.16E-03 
Dcn Decorin 0.98 1.67E-02 
Hspg2 Perlecan 2.17 5.03E-08 
Lum Lumican 1.00 1.70E-03 
Ogn Mimecan 0.74 1.63E-02 
Prelp Prolargin 0.79 6.16E-03 
Prg2 Bone marrow proteoglycan 0.87 2.82E-02 
A
f
fi
l
ia te d
 
p
r
o
t
e
i n s
 
Anxa1 Annexin A1 -1.33 2.24E-06 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
30 
 
Anxa11 Annexin A11 -0.68 9.76E-02 
Anxa2 Annexin A2 -2.03 2.63E-03 
Anxa3 Annexin A3  -2.92 6.12E-08 
Anxa5 Annexin A5 -3.76 2.32E-05 
Anxa6 Annexin A6 -2.19 1.73E-04 
Anxa7 Annexin A7 0.06 9.01E-02 
Lgals3 Galectin-3 0.41 2.70E-02 
Lgals9 Galectin-9 1.31 2.44E-02 
Sftpa1 
Pulmonary surfactant-associated 
protein A 
1.51 8.59E-06 
R
e
g
u
la
to
rs
 
Cstb Cystatin-B 2.49 2.21E-04 
Kng1 Kininogen-1 -0.76 6.03E-04 
Loxl1 Lysyl oxidase homolog 1 3.09 4.90E-07 
Plg Plasminogen -0.51 6.43E-02 
Pzp Pregnancy zone protein -1.67 1.04E-02 
Serpina1b Alpha-1-antitrypsin 1-2 -2.10 2.79E-02 
Serpina1c Alpha-1-antitrypsin 1-3 -2.68 1.37E-06 
Serpina1d Alpha-1-antitrypsin 1-4 -1.34 1.52E-04 
Serpina1e Alpha-1-antitrypsin 1-5 -1.71 1.85E-05 
Serpina3k Serine protease inhibitor A3K -1.55 3.56E-05 
Serpinh1 Serpin H1 1.93 5.92E-06 
Tgm2 
Protein-glutamine gamma-
glutamyltransferase 2 
1.28 5.78E-06 
S
e
c
re
t
e
d
 
p
ro
te
in
s
 Egfl7 
Epidermal growth factor-like protein 
7 
-3.62 1.41E-03 
S100a9 Protein S100-A9 -2.91 8.86E-06 
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Highlights 
 
 SWATH MS is capable of quantitative analysis of the matrisome in both non-enriched 
and ECM enriched tissues. 
 SWATH MS provides a more reproducible coverage of the matrisome compared to DDA 
MS. 
 Quantitative analysis by SWATH MS reveals that the lung has a higher matrisomal 
protein content versus the liver. 
 Comparative analysis finds that ECM enrichment leads to significant losses in 
matrisome-associated proteins. 
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